These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18700259)

  • 1. [How safe is our treatment with heparins? (interview by Maria Weiss)].
    Lindhoff-Last E
    MMW Fortschr Med; 2008 May; 150(22):7. PubMed ID: 18700259
    [No Abstract]   [Full Text] [Related]  

  • 2. New and generic anticoagulants and biosimilars: safety considerations.
    Kalodiki E; Fareed J
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):136-9. PubMed ID: 21159711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful heparin desensitization after anaphylactic shock due to heparin.
    Altintaş ND; Aybar Türkoğlu M; Bozkurt B; Topeli Iskit A; Karakaya G; Kalyoncu AF
    Tuberk Toraks; 2009; 57(1):68-72. PubMed ID: 19533440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contaminated heparins].
    Monneret C
    Ann Pharm Fr; 2008 Aug; 66(4):212-5. PubMed ID: 18847567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contaminants in heparins continue to be unfolded.
    Fareed J; Ahluwalia M; Wahi R; Ramaccioti E; Hoppensteadt D; Bick RL
    Int Angiol; 2008 Dec; 27(6):457-61. PubMed ID: 19078906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anaphylactoid reactions associated with contaminated heparin from China].
    Montpas N; Désormeaux A; Keire D; Adam A
    Ann Pharm Fr; 2011 Sep; 69(5):258-64. PubMed ID: 21924126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tainted heparin story: an update.
    Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
    Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
    [No Abstract]   [Full Text] [Related]  

  • 9. [Artificial polysaccharide in contaminated heparin. Acute hypersensitivity reactions explained--but how could it happen?].
    Lindahl U
    Lakartidningen; 2008 Sep 24-30; 105(39):2660-1. PubMed ID: 18846871
    [No Abstract]   [Full Text] [Related]  

  • 10. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
    McMahon AW; Pratt RG; Hammad TA; Kozlowski S; Zhou E; Lu S; Kulick CG; Mallick T; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):921-33. PubMed ID: 20661880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contaminants in heparins: are all facts known?
    Fareed J; Hoppensteadt DA; Ramacciotti E; Hull RD
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):242-3. PubMed ID: 20547552
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
    McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
    J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypersensitivity reaction and Chinese heparin].
    Désormeaux A; Montpas N; Adam A
    Ann Pharm Fr; 2009 May; 67(3):169-72. PubMed ID: 19446665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cytokine secretion from lymphocytes of patients with hypersensitivity reactions to contaminated heparins.
    Martin M; Ott H; Merk HF; Sachs B
    Br J Dermatol; 2011 Jan; 164(1):68-75. PubMed ID: 20854434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical killer unmasked.
    Perkel JM
    Anal Chem; 2008 Jul; 80(13):4789-90. PubMed ID: 18609746
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigation of direct toxic and teratogenic effects of anticoagulants on rat embryonic development using in vitro culture method and genotoxicity assay.
    Uysal II; Karabulut AK; Ozdemir K; Aksoy M; Altunkeser BB; Acar H
    Anat Histol Embryol; 2006 Apr; 35(2):84-92. PubMed ID: 16542172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Product-related adverse events in hemodialysis patients: improving recognition and response.
    Patel PR; Kallen AJ; Budnitz DS
    Am J Kidney Dis; 2010 May; 55(5):972; author reply 973. PubMed ID: 20438988
    [No Abstract]   [Full Text] [Related]  

  • 19. From crisis to opportunity: a perspective on the heparin crisis.
    Sasisekharan R; Shriver Z
    Thromb Haemost; 2009 Nov; 102(5):854-8. PubMed ID: 19888519
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypersensitivity reactions and deaths associated with intravenous iron preparations.
    Bailie GR; Clark JA; Lane CE; Lane PL
    Nephrol Dial Transplant; 2005 Jul; 20(7):1443-9. PubMed ID: 15855210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.